US4902679A
(en)
*
|
1985-12-13 |
1990-02-20 |
Norwich Eaton Pharmaceuticals, Inc. |
Methods of treating diseases with certain geminal diphosphonates
|
IL84494A
(en)
*
|
1986-11-21 |
1992-08-18 |
Ciba Geigy Ag |
Heteroaryl substituted aminomethane-diphosphonic acids,their preparation and pharmaceutical compositions containing them
|
DE3770787D1
(en)
*
|
1986-11-21 |
1991-07-18 |
Ciba Geigy Ag |
Aromatisch substituierte azacyclo-alkylalkandiphosphonsaeuren.
|
EP0275821B1
(de)
*
|
1986-11-21 |
1992-02-26 |
Ciba-Geigy Ag |
Neue substituierte Alkandiphosphonsäuren
|
US5057505A
(en)
*
|
1986-11-21 |
1991-10-15 |
Ciba-Geigy Corporation |
Substituted aminomethanediphosphonic acids and use in medicaments
|
DE3640938A1
(de)
*
|
1986-11-29 |
1988-06-01 |
Boehringer Mannheim Gmbh |
Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel
|
IL84731A0
(en)
*
|
1986-12-19 |
1988-05-31 |
Norwich Eaton Pharma |
Heterocycle-substituted diphosphonic acids and salts and esters and pharmaceutical compositions containing them
|
FR2611203B1
(fr)
*
|
1987-02-20 |
1989-06-09 |
Sturtz Georges |
Analogues gem-diphosphoniques d'amethopterine (methotrexate) et de derives deaza-n-10 amethopterine. leur preparation et les compositions pharmaceutiques qui les contiennent
|
US4973576A
(en)
*
|
1987-03-10 |
1990-11-27 |
Yamanouchi Pharmaceutical Co., Ltd. |
Bisphophonic acid derivatives and pharmaceutical compositions containing the same
|
KR880011136A
(ko)
*
|
1987-03-11 |
1988-10-26 |
모리오까 시게오 |
아졸- 아미노메틸렌 비스포스폰산 유도체
|
IL86951A
(en)
*
|
1987-07-06 |
1996-07-23 |
Procter & Gamble Pharma |
Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
|
EP0317505A1
(de)
*
|
1987-11-13 |
1989-05-24 |
Ciba-Geigy Ag |
Neue Azacycloalkylalkandiphosphonsäuren
|
EP0320455B1
(de)
*
|
1987-12-11 |
1993-06-09 |
Ciba-Geigy Ag |
Araliphatylaminoalkandiphosphonsäuren
|
US5110807A
(en)
*
|
1988-12-01 |
1992-05-05 |
Ciba-Geigy Corporation |
Araliphatylaminoalkanediphosphonic acids
|
US5190930A
(en)
*
|
1987-12-11 |
1993-03-02 |
Ciba-Geigy Corporation |
Araliphatylaminoalkanediphosphonic acids
|
US4933472A
(en)
*
|
1988-04-08 |
1990-06-12 |
Yamanouchi Pharmaceutical Co., Ltd. |
Substituted aminomethylenebis(phosphonic acid) derivatives
|
DE3822650A1
(de)
*
|
1988-07-05 |
1990-02-01 |
Boehringer Mannheim Gmbh |
Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
TW198039B
(nl)
*
|
1988-11-28 |
1993-01-11 |
Ciba Geigy Ag |
|
DE68910288T2
(de)
*
|
1988-12-14 |
1994-02-17 |
Pfizer |
Derivate von 5-Hydroxy- und 5-Methoxy-2-amino-pyrimidin als Inhibitoren der Interleukin-1-Produktion.
|
PH26923A
(en)
*
|
1989-03-08 |
1992-12-03 |
Ciba Geigy |
N-substituted amino alkanediphosphonic acids
|
FI83421C
(fi)
*
|
1989-06-21 |
1991-07-10 |
Huhtamaeki Oy |
Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
|
MX21452A
(es)
*
|
1989-07-07 |
1994-01-31 |
Ciba Geigy Ag |
Preparaciones farmaceuticas que se administran en forma topica.
|
US5139786A
(en)
*
|
1989-07-07 |
1992-08-18 |
Ciba-Geigy Corporation |
Topical formulations
|
FI89366C
(fi)
*
|
1990-12-20 |
1993-09-27 |
Leiras Oy |
Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat
|
CA2102303A1
(en)
*
|
1991-06-19 |
1992-12-20 |
Roy Allen Johnson |
Dialkyl (dialkoxyphosphinyl) methyl phosphates as anti-inflammatory agents
|
EP0522576A3
(en)
*
|
1991-07-12 |
1993-07-14 |
Hoechst Aktiengesellschaft |
Aminoethane-1,1-bisphosphonic acids and aminoethane-1,1-alkylphospinic/phosphonic acids, process of their preparation and their use
|
US6096342A
(en)
*
|
1997-03-12 |
2000-08-01 |
The Procter & Gamble Company |
Dosage forms of risedronate
|
KR100274734B1
(ko)
*
|
1991-11-22 |
2000-12-15 |
제이코버스 코넬리스 레이서 |
리제드로네이트 지연-방출성 조성물
|
TW222637B
(nl)
*
|
1991-12-12 |
1994-04-21 |
Hoechst Ag |
|
DE4141928A1
(de)
*
|
1991-12-19 |
1993-06-24 |
Boehringer Mannheim Gmbh |
Neue phosphonobernsteinsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
US5283057A
(en)
*
|
1992-04-24 |
1994-02-01 |
The Procter & Gamble Company |
Risedronate in oral compositions
|
US5731299A
(en)
*
|
1992-05-29 |
1998-03-24 |
The Procter & Gamble Company |
Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
|
US5753634A
(en)
*
|
1992-05-29 |
1998-05-19 |
The Procter & Gamble Company |
Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
|
JPH07507315A
(ja)
*
|
1992-05-29 |
1995-08-10 |
プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド |
カルシウムおよびホスフェート代謝異常治療用含硫ホスホネート化合物
|
US5763611A
(en)
*
|
1992-05-29 |
1998-06-09 |
The Procter & Gamble Company |
Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
|
SG47603A1
(en)
*
|
1992-05-29 |
1998-04-17 |
Procter & Gamble Pharma |
Thio-substitute nitrogen containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
|
DK0642518T3
(da)
*
|
1992-05-29 |
1998-12-14 |
Procter & Gamble Pharma |
Phosphonosulfonat-forbindelser til behandling af abnormt calcium- og phosphatstofskifte
|
IL105838A
(en)
*
|
1992-05-29 |
1998-03-10 |
Procter & Gamble Pharma |
Pharmaceutical compositions containing phosphonocarboxylates and some novel compounds of this type
|
US5760021A
(en)
*
|
1992-05-29 |
1998-06-02 |
The Procter & Gamble Company |
Phosphonocarboxylate compounds pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
|
CZ297094A3
(en)
*
|
1992-05-29 |
1995-12-13 |
Procter & Gamble Pharma |
Phosphate compounds containing quaternary nitrogen, their use and pharmaceutical compositions containing thereof
|
US5391743A
(en)
*
|
1992-05-29 |
1995-02-21 |
Procter & Gamble Pharmaceuticals, Inc. |
Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
|
JP4481368B2
(ja)
*
|
1992-06-30 |
2010-06-16 |
味の素株式会社 |
骨粗鬆症の治療用のためのホスホネート類の用途
|
CA2138366C
(en)
*
|
1992-06-30 |
1998-09-22 |
Kristine Hovancik |
Methods for the treatment of arthritis using phosphonates and nsaids
|
EP0663919A1
(en)
*
|
1992-10-09 |
1995-07-26 |
PHARMACIA & UPJOHN COMPANY |
Pyrimidine bisphosphonate esters as anti-inflamatories
|
ATE176476T1
(de)
*
|
1992-12-02 |
1999-02-15 |
Hoechst Ag |
Guanidinalkyl-1, 1-bisphosphonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung
|
CN1043423C
(zh)
*
|
1993-01-02 |
1999-05-19 |
曼海姆泊灵格股份公司 |
新膦酰基琥珀酸衍生物及其制备方法和含这些化合物的药物组合物
|
FR2703590B1
(fr)
*
|
1993-04-05 |
1995-06-30 |
Sanofi Elf |
Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
|
JPH06298779A
(ja)
*
|
1993-04-15 |
1994-10-25 |
Hoechst Japan Ltd |
ヘテロ環イミノビスメチレンビスホスホン酸誘導体
|
US5451401A
(en)
*
|
1993-09-29 |
1995-09-19 |
The Procter & Gamble Company |
Diphosphonic acid esters as tartar control agents
|
US5728650A
(en)
*
|
1993-10-07 |
1998-03-17 |
Zeneca Limited |
Herbicidal aza bisphosphonic acids and compositions containing the same
|
US20010007863A1
(en)
*
|
1998-06-18 |
2001-07-12 |
Merck & Co., Inc. |
Wet granulation formulation for bisphosphonic acids
|
SE9402001D0
(sv)
*
|
1994-06-09 |
1994-06-09 |
Leiras Oy |
Pyridylbisphosphonates for use as a therapeutical agent
|
US5880111A
(en)
*
|
1995-06-07 |
1999-03-09 |
Farcasiu; Dan |
Therapeutic derivations of diphosphonates
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
US6432932B1
(en)
|
1997-07-22 |
2002-08-13 |
Merck & Co., Inc. |
Method for inhibiting bone resorption
|
US5994329A
(en)
|
1997-07-22 |
1999-11-30 |
Merck & Co., Inc. |
Method for inhibiting bone resorption
|
IT1303672B1
(it)
*
|
1998-07-28 |
2001-02-23 |
Nicox Sa |
Sali nitrati di farmaci attivi nei disordini ossei
|
AU761267C
(en)
|
1998-09-09 |
2007-08-09 |
Metabasis Therapeutics, Inc. |
Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
|
US7205404B1
(en)
|
1999-03-05 |
2007-04-17 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing prodrugs
|
JP2003531111A
(ja)
|
1999-12-17 |
2003-10-21 |
アライアッド・ファーマシューティカルズ・インコーポレーテッド |
プロトンポンプインヒビター
|
IL150059A0
(en)
*
|
1999-12-17 |
2002-12-01 |
Ariad Pharma Inc |
Novel heterocycles
|
US6420384B2
(en)
*
|
1999-12-17 |
2002-07-16 |
Ariad Pharmaceuticals, Inc. |
Proton pump inhibitors
|
US6410520B2
(en)
*
|
2000-02-01 |
2002-06-25 |
The Procter & Gamble Company |
Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
|
US6562974B2
(en)
|
2000-02-01 |
2003-05-13 |
The Procter & Gamble Company |
Process for making geminal bisphosphonates
|
US7563774B2
(en)
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
PL194770B1
(pl)
*
|
2001-03-19 |
2007-07-31 |
Adamed Sp Z Oo |
Sposób wytwarzania kwasu rizedronowego
|
US6558702B2
(en)
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
US20060269602A1
(en)
*
|
2001-04-13 |
2006-11-30 |
Dasch James R |
Method of modifying the release profile of sustained release compositions
|
TWI315982B
(en)
|
2001-07-19 |
2009-10-21 |
Novartis Ag |
Combinations comprising epothilones and pharmaceutical uses thereof
|
WO2003055496A1
(en)
*
|
2001-12-21 |
2003-07-10 |
The Procter & Gamble Company |
Method for the treatment of bone disorders
|
US20050070504A1
(en)
*
|
2001-12-21 |
2005-03-31 |
The Procter & Gamble Co. |
Risedronate compositions and their methods of use
|
WO2003086415A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Merck & Co., Inc. |
Method for inhibiting bone resorption with an alendronate and vitamin d formulation
|
KR100937184B1
(ko)
*
|
2002-04-11 |
2010-01-19 |
테바 파마슈티컬 인더스트리즈 리미티드 |
리세드로네이트 나트륨의 신규한 동질이상체 및 유사동질이상체
|
TW200413381A
(en)
|
2002-11-04 |
2004-08-01 |
Hoffmann La Roche |
Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
|
US7358331B2
(en)
*
|
2003-05-19 |
2008-04-15 |
Elan Pharmaceuticals, Inc. |
Truncated fragments of alpha-synuclein in Lewy body disease
|
US20050065171A1
(en)
*
|
2003-06-25 |
2005-03-24 |
Shakespeare William C. |
Substituted purine derivatives
|
US20040265565A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Fischer Patrick J. |
Microporous article containing flame retardant
|
BRPI0413067A
(pt)
*
|
2003-07-30 |
2006-10-17 |
Procter & Gamble |
processo para controlar a estrututra cristalina do risedronato
|
CA2539359A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate
|
DE602004032577D1
(de)
*
|
2003-12-23 |
2011-06-16 |
Alchymars S P A |
Amorphe Form das Natriumsalzes der Ibandronsäure
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
DE602005001873T2
(de)
*
|
2004-03-03 |
2008-04-24 |
Chemi S.P.A., Cinisello Balsamo |
Amorphe 3-Pyridyl-1-Hydroxyethyliden-1,1-Bisphosphonsäure Mononatriumsalz und Verfahren zu deren Herstellung
|
WO2005107714A2
(en)
*
|
2004-05-05 |
2005-11-17 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
US20050261250A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Merck & Co., Inc., |
Compositions and methods for inhibiting bone resorption
|
KR20080083068A
(ko)
|
2004-05-24 |
2008-09-12 |
더 프록터 앤드 갬블 캄파니 |
킬레이팅제를 함유하는 비스포스포네이트의 고형의 장용 경구 투여 형태
|
ES2517840T3
(es)
*
|
2004-08-25 |
2014-11-04 |
University Of Iowa Research Foundation |
Inhibidores de la geranilgeranil pirofosfato sintasa
|
US7358361B2
(en)
*
|
2004-10-08 |
2008-04-15 |
The Board Of Trustees Of The University Of Illinois |
Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
|
US8012949B2
(en)
*
|
2004-10-08 |
2011-09-06 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
|
CA2590046A1
(en)
*
|
2004-11-09 |
2006-05-18 |
Jubilant Organosys Limited |
Process for preparing a pure polymorphic form of 3-pyridyl-1-hydroxyethylidine-1,1-bisphosphonic acid sodium salt
|
PL199215B1
(pl)
|
2004-12-28 |
2008-08-29 |
Politechnika Gdanska |
Sposób wytwarzania kwasu [1-hydroksy-2-(3-pirydylo)etylidenobisfosfonowego] oraz jego soli monosodowej dwu i pół wodnej
|
WO2006110656A2
(en)
|
2005-04-08 |
2006-10-19 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
US8642577B2
(en)
|
2005-04-08 |
2014-02-04 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of poxvirus infections
|
WO2006116057A2
(en)
*
|
2005-04-21 |
2006-11-02 |
Duke University |
Facilitated transport of bisphosphonates by vitamin c
|
CA2606879A1
(en)
*
|
2005-05-06 |
2007-03-01 |
Medichem, S.A. |
Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof
|
WO2007026379A2
(en)
*
|
2005-08-30 |
2007-03-08 |
Natco Pharma Limited |
Novel crystalline forms of risedronate monosodium
|
EP1775302A1
(en)
|
2005-10-11 |
2007-04-18 |
Sandoz A/S |
Method for preparing crystalline sodium risedronate
|
CA2646334A1
(en)
*
|
2006-03-17 |
2007-09-27 |
The Board Of Trustees Of The University Of Illinois |
Bisphosphonate compounds and methods
|
JP5354858B2
(ja)
*
|
2006-05-09 |
2013-11-27 |
株式会社Adeka |
スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
|
KR20090005206A
(ko)
|
2006-05-11 |
2009-01-12 |
인드-스위프트 래버러토리즈 리미티드 |
순수한 리세드론산 또는 염의 제조 방법
|
PT103600B
(pt)
|
2006-11-06 |
2009-01-30 |
Hovione Farmaciencia Sa |
Processo para a preparação de ácidos biosfónicos e seus sais farmaceuticamente aceitáveis
|
US7781418B2
(en)
|
2006-12-14 |
2010-08-24 |
Isis Innovation Ltd. |
Composition for treating bone disorders
|
US20110039804A1
(en)
|
2006-12-20 |
2011-02-17 |
Landsteiner Scientific, S.A. De C.V. |
Composition of Risedronate and Vitamin D3
|
WO2009050731A2
(en)
*
|
2007-06-20 |
2009-04-23 |
Alkem Laboratories Ltd |
Novel process for preparing risedronic acid
|
DE102007030370A1
(de)
|
2007-06-29 |
2009-01-02 |
Ratiopharm Gmbh |
Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese
|
US20090075940A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched risedronate
|
ITPA20070034A1
(it)
*
|
2007-10-30 |
2009-04-30 |
Tetrapharm S R L |
Bifosfonati geminali, loro preparazione e loro impiego in campo oncologico.
|
WO2009105140A2
(en)
|
2007-12-11 |
2009-08-27 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
EP2254582B1
(en)
|
2008-01-25 |
2016-01-20 |
Chimerix, Inc. |
Methods of treating viral infections
|
TR200900878A2
(tr)
|
2009-02-05 |
2010-08-23 |
Bi̇lgi̇ç Mahmut |
Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
|
WO2011011519A1
(en)
|
2009-07-21 |
2011-01-27 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
BR112012002551A2
(pt)
|
2009-08-03 |
2017-06-13 |
Chimerix Inc |
composição e métodos de tratamento de infecções virais e tumores induzidos por vírus
|
FR2954320B1
(fr)
|
2009-12-17 |
2012-06-15 |
Cll Pharma |
Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
|
WO2011100698A2
(en)
|
2010-02-12 |
2011-08-18 |
Chimerix, Inc. |
Methods of treating viral infection
|
EP2563367A4
(en)
|
2010-04-26 |
2013-12-04 |
Chimerix Inc |
METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES
|
TR201100149A2
(tr)
|
2011-01-06 |
2012-07-23 |
Bi̇lgi̇ç Mahmut |
Geliştirilmiş risedronat formülasyonu.
|
WO2012093974A1
(en)
|
2011-01-06 |
2012-07-12 |
Mahmut Bilgic |
Improved bisphosphonate formulations
|
CN102286024B
(zh)
*
|
2011-08-30 |
2013-12-04 |
江苏正大清江制药有限公司 |
利塞膦酸钠的合成方法
|
GB201200868D0
(en)
|
2012-01-19 |
2012-02-29 |
Depuy Int Ltd |
Bone filler composition
|
AU2013286683B2
(en)
|
2012-07-05 |
2017-07-13 |
University Of Iowa Research Foundation |
Therapeutic bisphosphonates
|
EP3105238A4
(en)
|
2014-02-13 |
2017-11-08 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and their uses
|
WO2016003812A1
(en)
|
2014-07-02 |
2016-01-07 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and uses therof
|
WO2017011686A1
(en)
|
2015-07-14 |
2017-01-19 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
KR102116528B1
(ko)
*
|
2015-09-09 |
2020-05-28 |
칭화 유니버시티 |
고-효율 백신 아쥬반트로서 메발로네이트 경로 억제제
|
CA3102210C
(en)
|
2015-11-02 |
2022-06-14 |
Pura Scents, Inc. |
Scent dispensation
|
USD816506S1
(en)
|
2015-11-02 |
2018-05-01 |
Pura Scents, Inc. |
Vial for a scent dispenser
|
USD809116S1
(en)
|
2015-11-02 |
2018-01-30 |
Pura Scents |
Dispenser
|
CN111788196A
(zh)
|
2018-01-09 |
2020-10-16 |
配体药物公司 |
缩醛化合物及其治疗用途
|